Astrana Health, Inc. (ASTH) has a MoatMap StockRank of 96/100 based on Quality (50/100), Value (48/100), and Momentum (89/100) factor scores. The current signal is STRONG BUY. Astrana Health, a US healthcare company, has a low quality score (34). This suggests it does not possess the high ROIC, pricing power, or durable moat required for a quality compounder, and there is no specific macro tailwind to create an asymmetric opportunity.
Astrana Health, Inc. (formerly Apollo Medical Holdings) is an integrated healthcare delivery and technology company that provides value-based care management services, primarily to Medicare Advantage members. Its competitive moat is built on a physician-centric, integrated care model that leverages proprietary technology and data analytics to improve patient outcomes and reduce costs for complex populations. Astrana Health is a leading innovator in value-based care, focused on risk-bearing contracts and delivering comprehensive, coordinated care.
| Price | $37.85 |
| Market Cap | $1.9B |
| P/E (TTM) | 64.43 |
| P/E (Forward) | 11.52 |
| Price/Book | 2.40 |
| Return on Equity | 5.7% |
| Return on Invested Capital | 5.6% |
| Debt/Equity | 184.46 |
| Gross Margin | 10.7% |
| Operating Margin | 3.0% |
| Revenue Growth | 55.6% |
| Free Cash Flow | $288M |
Astrana Health, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).